Magnesiumsulfat Kalceks

Magnesium sulfate, the active ingredient in Magnesiumsulfat Kalceks, is an electrolyte presented as a sterile solution for intramuscular, intravenous, and subcutaneous use. It replenishes magnesium ions and is employed to correct magnesium deficiency and support neuromuscular and cardiac function in hospitalized patients.

GNH USA supplies Magnesiumsulfat Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies, clinics and other healthcare facilities worldwide, with a focus on quality and regulatory compliance.

Magnesium sulfate is used to manage conditions related to magnesium deficiency and electrolyte imbalance.

- Hypomagnesemia: restores serum magnesium concentrations in patients with low magnesium levels. - Pre‑eclampsia/Eclampsia: prevents and treats seizures in pregnant women with severe hypertension. - Torsades de pointes: stabilises cardiac rhythm in polymorphic ventricular tachycardia. - Severe asthma exacerbation (adjunct): relaxes bronchial smooth muscle to improve airflow.

Adverse reactions may occur with magnesium sulfate administration.

Common Side Effects: - Injection site pain: discomfort at the site of intramuscular or intravenous injection. - Flushing: transient warmth and redness of the skin. - Hypotension: mild drop in blood pressure. - Nausea: feeling of unease in the stomach. - Vomiting: expulsion of stomach contents. - Headache: mild to moderate cranial pain.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure reduction requiring intervention. - Cardiac arrhythmias: abnormal heart rhythms, including bradycardia. - Respiratory depression: reduced breathing effort. - Hypermagnesemia: muscle weakness, loss of deep tendon reflexes, and possible cardiac arrest. - Cardiac arrest: cessation of heart activity in extreme cases.

Magnesium sulfate should be used with careful clinical monitoring.

- Renal impairment: monitor serum magnesium and adjust dose. - Cardiac disease: use cautiously in patients with conduction abnormalities. - Neuromuscular disorders: assess reflexes and muscle strength regularly. - Pregnancy: administer only when benefits outweigh potential risks. - Concomitant calcium‑channel blockers: monitor for additive hypotensive effects. - Store below 25°C: keep in the original container, protect from moisture and light.

Magnesium sulfate can interact with several medicines.

Major Interactions (Avoid): - Calcium‑channel blockers: additive hypotensive effect. - Neuromuscular blocking agents: prolonged paralysis. - High‑dose potassium supplements: risk of severe hypermagnesemia.

Moderate Interactions (Monitor Closely): - Aminoglycoside antibiotics: reduced antibacterial efficacy. - Potassium‑sparing diuretics: increased risk of hypermagnesemia. - ACE inhibitors or ARBs: monitor renal function and electrolyte balance.